118 results
8-K
EX-1.1
SLNO
Soleno Therapeutics Inc
7 May 24
Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering of Common Stock
5:28pm
, social security number or tax identification number, driver’s license number, passport number, credit card number, bank information, or customer … in a Material Adverse Effect, the Company and each Subsidiary has accurately prepared and timely filed all federal, state, foreign and other tax
424B5
SLNO
Soleno Therapeutics Inc
6 May 24
Prospectus supplement for primary offering
4:58pm
Income Tax Consequences To Non-U.S. Holders
S-18
Underwriting
S-25
Legal Matters
S-32
Experts
S-32
Where You Can Find More Information
S-32
Incorporation … outstanding.
S-17
MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO NON-U.S. HOLDERS
The following discussion describes the material U.S. federal income tax
424B5
SLNO
Soleno Therapeutics Inc
2 May 24
Prospectus supplement for primary offering
4:04pm
S-12
Use of Proceeds
S-13
Dividend Policy
S-14
Dilution
S-15
Description of The Securities We Are Offering
S-17
Material U.S. Federal Income Tax … shares of common stock outstanding.
S-17
MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO NON-U.S. HOLDERS
The following discussion describes
8-K
EX-10.1
cgkxyz1
30 Jan 24
Departure of Directors or Certain Officers
4:57pm
S-3ASR
31l akspg7alvhw076
2 Jan 24
Automatic shelf registration
4:06pm
S-3ASR
EX-4.3
uc04iang6z0tjhgw cw
2 Jan 24
Automatic shelf registration
4:06pm
8-K
EX-1.1
nst2ezojjhgbaxp8usa
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-10.2
oscyz iyvraf
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-10.1
phyubjl vzngjxzrtbi1
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
424B5
u7iqu e5k2j2
29 Sep 23
Prospectus supplement for primary offering
4:51pm
424B5
k44sghka2k2nqxtvs
27 Sep 23
Prospectus supplement for primary offering
5:26pm